The TSC1-TSC2 complex consists of multiple TSC1 and TSC2 subunits

BMC Biochemistry

Volumn 13, Issue 1, 2012, Pages

  Hoogeveen Westerveld, Marianne ^a   Van Unen, Leontine ^a   Van Den Ouweland, Ans ^a   Halley, Dicky ^a   Hoogeveen, Andre ^a   Nellist, Mark ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Quaternary structure; TSC1; TSC1 TSC2 complex; TSC2

Indexed keywords

ISOPROTEIN; MULTIPROTEIN COMPLEX; PROTEIN; PROTEIN TUBEROUS SCLEROSIS COMPLEX 1; TUBERIN; UNCLASSIFIED DRUG;

ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ELUTION; EMBRYO; GEL FILTRATION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PROTEIN QUATERNARY STRUCTURE; PROTEIN SUBUNIT;

EID: 84866519139     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-13-18     Document Type: Article

References (34)

1. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. van Slegtenhorst M, de Hoogt R, Hermans C, Nellist M, Janssen LAJ, Verhoef S, Lindhout D, van den Ouweland AMW, Halley DJJ, Young J, Burley M, Jeremiah S, Woodward K, Nahmias J, Fox M, Ekong R, Wolfe J, Povey S, Osborne J, Snell RG, Cheadle JP, Jones AC, Tachataki M, Ravine D, Sampson JR, Reeve MP, Richardson P, Wilmer F, Munro C, Hawkins TL, Sepp T, Ali JBM, Ward S, Green AJ, Yates JRW, Short MP, Haines JH, Jozwiak S, Kwiatkowska J, Henske EP, Kwiatkowski DJ, Science 1997 277 805 808 10.1126/science.277.5327.805 9242607 (Pubitemid 27366729)
2. Identification and characterization of the tuberous sclerosis gene on chromosome 16. European Chromosome 16 Tuberous Sclerosis Consortium, Cell 1993 75 1305 1315 8269512
3. The tuberous sclerosis complex Oxford: University Press, Gomez M, Sampson J, Whittemore V, 1999
4. Metastasis of benign tumor cells in tuberous sclerosis complex. Henske EP, Genes Chromosomes Cancer 2003 38 376 381 10.1002/gcc.10252 14566858 (Pubitemid 37466939)
5. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. van Slegtenhorst M, Nellist M, Nagelkerken B, Cheadle J, Snell R, van den Ouweland A, Reuser A, Sampson JR, Halley D, van der Sluijs P, Hum Mol Genet 1998 7 1053 1057 10.1093/hmg/7.6.1053 9580671 (Pubitemid 28256600)
6. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. Nellist M, Verhaaf B, Goedbloed MA, Reuser AJJ, van den Ouweland AMW, Halley DJJ, Hum Mol Genet 2001 10 2889 2898 10.1093/hmg/10.25.2889 11741832 (Pubitemid 34030920)
7. Analysis of TSC1 truncations defines regions involved in TSC1 stability, aggregation and interaction. Hoogeveen-Westerveld M, Exalto C, Maat-Kievit A, van den Ouweland A, Halley D, Nellist M, Biochim Biophys Acta 2010 1802 774 781 10.1016/j.bbadis.2010.06.004 20547222
8. TSC2: filling the GAP in the mTOR signaling pathway. Li Y, Corradetti MN, Inoki K, Guan K-L, Trends Biochem Sci 2003 28 573 576 10.1016/j.tibs.2003.09. 003 14607085 (Pubitemid 38352801)
9. Defining the role of mTOR in cancer. Guertin DA, Sabatini DM, Cancer Cell 2007 12 9 22 10.1016/j.ccr.2007.05.008 17613433 (Pubitemid 47001784)
10. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Huang J, Manning BD, Biochem J 2008 412 179 190 10.1042/BJ20080281 18466115 (Pubitemid 351758225)
11. The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Benvenuto G, Li S, Brown SJ, Braverman R, Vass WC, Cheadle JP, Halley DJ, Sampson JR, Wienecke R, DeClue JE, Oncogene 2000 19 6306 6316 10.1038/sj.onc.1204009 11175345 (Pubitemid 32641844)
12. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. Cai SL, Tee AR, Short JD, Bergeron JM, Kim J, Shen J, Guo R, Johnson CL, Kiguchi K, Walker CL, J Cell Biol 2006 173 279 289 10.1083/jcb.200507119 16636147
13. Warton CW, Eisenthal R, Molecular Enzymology Glasgow: Blackie 1981
14. Caught in self-interaction: evolutionary and functional mechanisms of protein homooligomerization. Hashimoto K, Nishi H, Bryant S, Panchenko AR, Phys Biol 2011 8 035007 10.1088/1478-3975/8/3/035007 21572178
15. Characterization of the cytosolic tuberin-hamartin complex: tuberin is a cytosolic chaperone for hamartin. Nellist M, van Slegtenhorst MA, Goedbloed M, van den Ouweland AMW, Halley DJJ, van der Sluijs P, J Biol Chem 1999 274 35647 35652 10.1074/jbc.274.50.35647 10585443 (Pubitemid 129512864)
16. N-terminal hamartin-binding and C-terminal GAP domain of tuberin can separate in vivo. Momose S, Kobayashi T, Tada N, Itoyama S, Hino O, Biochem Biophys Res Comm 2007 356 693 698 10.1016/j.bbrc.2007.03.036 17379185 (Pubitemid 46499019)
17. Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC, Nellist M, Yeung RS, Halley DJ, Nicosia SV, Pledger WJ, Cheng JQ, J Biol Chem 2002 277 35364 35370 10.1074/jbc.M205838200 12167664
18. Distinct effects of single amino acid changes to tuberin on the function of the tuberin-hamartin complex. Nellist M, Sancak O, Goedbloed MA, Rohe C, van Netten D, Mayer K, Tucker-Williams A, van den Ouweland AMW, Halley DJJ, Eur J Hum Genet 2005 13 59 68 10.1038/sj.ejhg.5201276 15483652
19. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL, Nat Genet 1993 4 335 340 10.1038/ng0893-335 8401578 (Pubitemid 23231479)
20. A reliable cell-based assay for testing unclassified TSC2 gene variants. Coevoets R, Arican S, Hoogeveen-Westerveld M, Simons E, van den Ouweland A, Halley D, Nellist M, Eur J Hum Genet 2009 17 301 310 10.1038/ejhg.2008.184 18854862
21. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential. Ahmed NN, Franke TF, Bellacosa A, Datta K, Gonzalez-Portal ME, Taguchi T, Testa JR, Tsichlis PN, Oncogene 1993 8 1957 1963 8510938 (Pubitemid 23212429)
22. Molecular organization of target of rapamycin complex 2. Wullschleger S, Loewith R, Oppliger W, Hall MN, J Biol Chem 2005 280 30697 30704 10.1074/jbc.M505553200 16002396 (Pubitemid 41291798)
23. Activation of mammalian target of rapamycin (mTOR) by insulin is associated with stimulation of 4EBP1 binding to dimeric mTOR complex 1. Wang L, Rhodes CJ, Lawrence JC, J Biol Chem 2006 281 24293 24303 10.1074/jbc.M603566200 16798736 (Pubitemid 44274202)
24. Nutrient-dependent multimerization of the mammalian target of rapamycin through the N-terminal HEAT repeat region. Takahara T, Hara K, Yonezawa K, Sorimachi H, Maeda T, J Biol Chem 2006 281 28605 28614 10.1074/jbc.M606087200 16870609 (Pubitemid 44507003)
25. Oligomerization properties of fragile-X mental retardation protein (FMRP) and the fragile-X-related proteins FXR1P and FXR2P. Tamanini F, van Unen L, Bakker C, Sacchi N, Galjaard H, Oostra BA, Hoogeveen AT, Biochem J 1999 343 517 523 10.1042/0264-6021:3430517 10527928 (Pubitemid 29537361)
26. Localization of Rheb to the endomembrane is critical for its signalling function. Beurger S, DeVries B, Stambolic V, Biochem Biophys Res Commun 2006 344 869 880 10.1016/j.bbrc.2006.03.220 16631613
27. Identification and characterization of the interaction between tuberin and 14-3-3 Nellist M, Goedbloed MA, de Winter C, Verhaaf B, Jankie A, Reuser AJJ, van den Ouweland AMW, van der Sluijs P, Halley DJJ, J Biol Chem 2002 277 39417 39424 10.1074/jbc.M204802200 12176984 (Pubitemid 35190916)
28. Regulation of TSC2 by 14-3-3 binding. Li Y, Inoki K, Yeung R, Guan K-L, J Biol Chem 2002 277 44593 44596 10.1074/jbc.C200510200 12364343 (Pubitemid 36159047)
29. Tuberous sclerosis tumor suppressor complex-like complexes act as GTPase-activating proteins for Ral GTPases. Shirakawa R, Fukai S, Kawato M, Higashi T, Kondo H, Ikeda T, Nakayama E, Okawa K, Nureki O, Kimura T, Kita T, Horiuchi H, J Biol Chem 2009 284 21580 21588 10.1074/jbc.M109.012112 19520869
30. Adipocytes contain a novel complex similar to the tuberous sclerosis complex. Gridley S, Chavez JA, Lane WS, Lienhard GE, Cell Signal 2006 18 1626 1632 10.1016/j.cellsig.2006.01.002 16490346 (Pubitemid 44216120)
31. A Ral GAP complex links PI 3-kinase/Akt signaling to RalA activation in insulin action. Chen X-W, Leto D, Xiong T, Yu G, Cheng A, Decker S, Saltiel AR, Molec. Biol. Cell 2011 22 141 152 10.1091/mbc.E10-08-0665 21148297
32. Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N, Vazquez F, Carpenter CL, Kwiatkowski DJ, J Clin Invest 2003 112 1223 1233 14561707 (Pubitemid 38056299)
33. Functional assessment of variants in the TSC1 and TSC2 genes identified in individuals with tuberous sclerosis complex. Hoogeveen-Westerveld M, Wentink M, van den Heuvel D, Mozaffari M, Ekong R, Povey S, den Dunnen JT, Metcalfe K, Vallee S, Krueger S, Bergoffen J, Shashi V, Elmslie F, Kwiatkowski D, Sampson J, Vidales C, Dzarir J, Garcia-Planells J, Dies K, Maat-Kievit A, van den Ouweland A, Halley D, Nellist M, Hum Mutat 2011 32 424 435 10.1002/humu.21451 21309039
34. Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Jansen AC, Sancak O, D'Agostino MD, Badhwar A, Roberts P, Gobbi G, Wilkinson R, Melanson D, Tampieri D, Koenekoop R, Gans M, Maat-Kievit A, Goedbloed M, van den Ouweland AMW, Nellist M, Pandolfo M, McQueen M, Sims K, Thiele EA, Dubeau F, Andermann F, Kwiatkowski DJ, Halley DJJ, Andermann E, Ann Neurol 2006 60 528 539 10.1002/ana.21037 17120248 (Pubitemid 44871795)